Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Conditions:   Adrenocortical Carcinoma;   Adrenal Cancer;   ACCIntervention:   Drug: ATR-101Sponsor:   Atterocor, Inc.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2013 Category: Research Source Type: clinical trials

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Conditions:   Adrenocortical Carcinoma;   Peritoneal CarcinomatosisInterventions:   Drug: Cisplatin;   Procedure: Cytoreductive surgerySponsor:   National Cancer Institute (NCI)Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2013 Category: Research Source Type: clinical trials

A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients
Conditions:   Cancer;   Neuroendocrine Tumors;   NET;   Adrenocortical Carcinoma;   ACCIntervention:   Drug: TKM-080301Sponsor:   Tekmira Pharmaceuticals CorporationActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2010 Category: Research Source Type: clinical trials